HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Toshihito Furukawa Selected Research

K 130

1/2020Imaging Identification of Rapidly Progressing Autosomal Dominant Polycystic Kidney Disease: Simple Eligibility Criterion for Tolvaptan.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Toshihito Furukawa Research Topics

Disease

1Chronic Kidney Failure (Chronic Renal Failure)
01/2020
1Autosomal Dominant Polycystic Kidney (ADPKD)
01/2020

Drug/Important Bio-Agent (IBA)

1K 130IBA
01/2020
1TolvaptanFDA Link
01/2020